EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy

Anton N Bokatyi iD, Natallia V Dubashynskaya iD, Igor V Kudryavtsev, Andrey S Trulioff, Artem A Rubinstein iD, Elena N Vlasova, Yury A Skorik iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anton N Bokatyi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Branch of Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute"-Institute of Macromolecul…. Hauptthemen laut MEDLINE: Dexamethasone, Hyaluronic Acid, Anti-Inflammatory Agents, Drug Carriers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The covalent conjugation of pharmaceutical compounds to polymeric carriers represents an effective strategy for enhancing drug properties, including improved bioavailability, targeted delivery, and sustained release, while reducing systemic toxicity and adverse effects. By exploiting the physicochemical characteristics of biopolymers—particularly molecular charge and weight—we engineered a polymeric platform for glucocorticoid delivery with precisely controlled parameters including particle size, surface charge, targeting capability, and release kinetics. This study reports a linker-free synthesis of hyaluronic acid-dexamethasone (HA-DEX) conjugates through Steglich esterification, catalyzed by 4-dimethylaminopyridine (DMAP), which facilitates the acylation of sterically hindered alcohols. The reaction specifically couples carboxyl groups of hyaluronic acid with the C21 hydroxyl group of dexamethasone. Incorporation of hydrophobic dexamethasone moieties induced self-assembly into nanoparticles featuring a hydrophobic core and negatively charged hydrophilic shell (−20 to −25 mV ζ-potential). In vitro characterization revealed pH-dependent release profiles, with 80–90% dexamethasone liberated in mildly acidic phosphate buffer (pH 5.2) versus 50–60% in phosphate-buffered saline (pH 7.4) over 35 days, demonstrating both sustained release and inflammation-responsive behavior. The conjugates exhibited potent anti-inflammatory activity in a human tumor necrosis factor-α (TNFα)-induced inflammation model. These findings position HA-DEX conjugates as promising candidates for targeted glucocorticoid delivery to specific anatomical sites including ocular, articular, and tympanic tissues, where their combination of CD44-targeting capability, enhanced permeability and retention effects, and stimulus-responsive release can optimize therapeutic outcomes while minimizing off-target effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneHyaluronic AcidAnti-Inflammatory AgentsDrug CarriersNanoparticlesHydrogen-Ion ConcentrationHumansAnimalsDrug LiberationMiceDrug Delivery Systems

Stichwörter der Autor:innen

anti-inflammatory activitydexamethasonehyaluronic acidpolymeric drug delivery systems

Substanzen

DexamethasoneHyaluronic AcidAnti-Inflammatory AgentsDrug Carriers

Autor:innen und Institutionen

  • Branch of Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute"-Institute of Macromolecular Compounds, Bolshoi VO 31, Saint Petersburg 199004, Russia.
  • Institute of Experimental Medicine, Acad. Pavlov St. 12, Saint Petersburg 197376, Russia.

ORCID-Profile: Anton N Bokatyi, Natallia V Dubashynskaya, Artem A Rubinstein, Yury A Skorik

Förderung

  • Russian Science Foundation

Zitieren

APA

Bokatyi, A. N., Dubashynskaya, N. V., Kudryavtsev, I. V., Trulioff, A. S., Rubinstein, A. A., Vlasova, E. N., & Skorik, Y. A. (2025). Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146608

Vancouver

Bokatyi AN, Dubashynskaya NV, Kudryavtsev IV, Trulioff AS, Rubinstein AA, Vlasova EN, et al. Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146608

BibTeX
@article{Bokatyi2025,
  author = {Bokatyi, Anton N and Dubashynskaya, Natallia V and Kudryavtsev, Igor V and Trulioff, Andrey S and Rubinstein, Artem A and Vlasova, Elena N and Skorik, Yury A},
  title = {Linker-Free Hyaluronic Acid-Dexamethasone Conjugates: pH-Responsive Nanocarriers for Targeted Anti-Inflammatory Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146608}
}
Kostenlos starten →